PRLB
Proto Labs Inc
$76.14
+4.82%
$1.8B
No data for this timeframe.
Vol
Market Cap$1.8B
Cap SizeSmall Cap
Inst. Holders7 funds
Inst. Value$206.1M
Inst. Activity1 buys / 2 sells
Insider Activity0B / 5S
Insider Net $-$910.6K
SEC Reports3
Recent Activity
Jun 2, 2026
Insider
WEHRWEIN SVEN sold 1,500 shares
Director @ $76.91 ($115.4K)
May 23, 2026
Insider
Krishna Suresh sold 1,247 shares
President and CEO @ $71.36 ($89.0K)
May 20, 2026
SEC
Proto Labs held its 2026 annual meeting on May 19, 2026, where shareholders elected all seven director nominees, ratifie
8-K — Impact 2/10
May 20, 2026
Insider
Parlange Bernardo sold 3,789 shares
Chief Commercial Officer @ $0.00 ($0.00)
May 7, 2026
SEC
Proto Labs announced the planned retirement of COO Michael Kenison (effective July 1, 2026) and the appointment of Berna
8-K — Impact 2/10
Apr 8, 2026
SEC
Proto Labs Inc filed a definitive additional proxy statement (DEFA14A) related to an upcoming shareholder meeting. The f
DEFA14A — Impact 2/10
Inst.
BANK OF AMERICA CORP — TRIM
93,329 shares ($4.7M)
Inst.
WELLS FARGO & COMPANY/MN — ADD
29,974 shares ($1.5M)
Price Targets
Historical data — last covering-analyst action Nov 2025. No current recommendation available.
$75.67 (Nov 2025)
Current $75.48
Low $70.00
Median $75.00
High $82.00
3 analysts
$70.00
$82.00
Analyst Ratings
2Strong Buy
6Buy
3Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Nov 3, 2025 | Benchmark | MAINTAIN | Buy → Buy |
| Aug 1, 2025 | Cantor Fitzgerald | MAINTAIN | Overweight → Overweight |
| Feb 10, 2025 | Cantor Fitzgerald | MAINTAIN | Overweight → Overweight |
| Feb 7, 2025 | Needham | REITERATE | Hold → Hold |
| Jan 16, 2025 | Needham | REITERATE | Hold → Hold |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.54 | $0.52 — $0.55 | 31% YoY | 5 |
| Next Q | $0.51 | $0.48 — $0.55 | 9% YoY | 5 |
| Current FY | $2.03 | $1.97 — $2.10 | 22% YoY | 5 |
| Next FY | $2.21 ▲ +11.3% | $2.15 — $2.26 | 9% YoY | 4 |
Latest Reports
NEUTRAL
8-K
2/10
Proto Labs held its 2026 annual meeting on May 19, 2026, where shareholders elected all seven director nominees, ratifie
May 20, 2026
NEUTRAL
8-K
2/10
Proto Labs announced the planned retirement of COO Michael Kenison (effective July 1, 2026) and the appointment of Berna
May 7, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $134.9M | — |
| RENAISSANCE TECHNOLOGIES LLC | $25.0M | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $18.4M | NEW |
| MORGAN STANLEY | $15.5M | TRIM |
| FMR LLC | $6.2M | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 2, 2026 | WEHRWEIN SVEN | SELL | $115.4K |
| May 23, 2026 | Krishna Suresh | F | $89.0K |
| May 20, 2026 | Parlange Bernardo | A | $0.00 |
| May 20, 2026 | Schumacher Daniel | F | $18.1K |
| May 20, 2026 | Parlange Bernardo | A | $0.00 |
7 institutional holders with $206.1M total value (4,073,806 shares) as of 2025-Q4. Top holders: VANGUARD, RENAISSANCE, CHARLES. Net selling activity: 2 institutions trimmed/exited vs 1 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 2,666,227 | $134.9M | 65.4% | — |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 493,551 | $25.0M | 12.1% | — |
| 3 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 363,013 | $18.4M | 8.9% | NEW |
| 4 | MORGAN STANLEY | 305,612 | $15.5M | 7.5% | TRIM -25.9% |
| 5 | FMR LLC | 122,100 | $6.2M | 3.0% | ADD +26.0% |
| 6 | BANK OF AMERICA CORP /DE/ | 93,329 | $4.7M | 2.3% | TRIM -29.5% |
| 7 | WELLS FARGO & COMPANY/MN | 29,974 | $1.5M | 0.7% | ADD +37.3% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | TRIM | 132,361 | 93,329 | -29.5% | $4.7M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 21,833 | 29,974 | +37.3% | $1.5M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 4,500 | 0 | -100.0% | $0.00 | 2025-Q4 |
| MORGAN STANLEY | TRIM | 413,097 | 305,997 | -25.9% | $15.3M | 2025-Q3 |
| UBS Group AG | TRIM | 241,840 | 176,880 | -26.9% | $8.8M | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | ADD | 68,262 | 132,361 | +93.9% | $6.6M | 2025-Q3 |
| FMR LLC | ADD | 79,522 | 100,196 | +26.0% | $5.0M | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 99,286 | 68,262 | -31.2% | $2.7M | 2025-Q2 |
| UBS Group AG | ADD | 181,263 | 265,160 | +46.3% | $9.3M | 2025-Q1 |
| FMR LLC | DOUBLED | 32,765 | 69,179 | +111.1% | $2.4M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 14,971 | 6,600 | -55.9% | $231.3K | 2025-Q1 |
| NORGES BANK | EXIT | 49,800 | 0 | -100.0% | $0.00 | 2025-Q1 |
| UBS Group AG | DOUBLED | 68,213 | 181,263 | +165.7% | $7.1M | 2024-Q4 |
| CITADEL ADVISORS LLC | ADD | 82,521 | 109,489 | +32.7% | $4.3M | 2024-Q4 |
| NORGES BANK | NEW | — | 49,800 | — | $1.9M | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 330,798 | — | $9.7M | 2024-Q3 |
10 unique insiders with 5 transactions. Net insider value: -$910.6K ($0.00 bought, $910.6K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | WEHRWEIN SVEN | Director | SELL | 1,500 | $76.91 | $115.4K |
| May 23, 2026 | Krishna Suresh | President and CEO | F | 1,247 | $71.36 | $89.0K |
| May 20, 2026 | Parlange Bernardo | Chief Commercial Officer | A | 3,789 | $0.00 | $0.00 |
| May 20, 2026 | Schumacher Daniel | Chief Financial Officer | F | 255 | $71.13 | $18.1K |
| May 20, 2026 | Parlange Bernardo | Chief Commercial Officer | A | 2,109 | $0.00 | $0.00 |
| May 19, 2026 | WEHRWEIN SVEN | Director | A | 2,210 | $0.00 | $0.00 |
| May 19, 2026 | Chand Sujeet | Director | A | 2,210 | $0.00 | $0.00 |
| May 19, 2026 | Gawlick Rainer | Director | A | 2,210 | $0.00 | $0.00 |
| May 19, 2026 | Chin Moonhie | Director | A | 2,210 | $0.00 | $0.00 |
| May 19, 2026 | Black Archie C. | Director | A | 2,210 | $0.00 | $0.00 |
| May 19, 2026 | KRANTZ DONALD G | Director | A | 2,210 | $0.00 | $0.00 |
| May 12, 2026 | Kenison Michael R. | Chief Operations Officer | M | 1,928 | $33.84 | $65.2K |
| May 12, 2026 | Kenison Michael R. | Chief Operations Officer | SELL | 1,613 | $67.58 | $109.0K |
| May 12, 2026 | Kenison Michael R. | Chief Operations Officer | M | 1,928 | $0.00 | $0.00 |
| May 11, 2026 | Kenison Michael R. | Chief Operations Officer | M | 3,756 | $33.84 | $127.1K |
| May 11, 2026 | Kenison Michael R. | Chief Operations Officer | SELL | 7,433 | $70.26 | $522.3K |
| May 11, 2026 | Kenison Michael R. | Chief Operations Officer | M | 3,756 | $0.00 | $0.00 |
| May 7, 2026 | Kenison Michael R. | Chief Operations Officer | M | 100 | $33.84 | $3.4K |
| May 7, 2026 | Kenison Michael R. | Chief Operations Officer | SELL | 200 | $70.00 | $14.0K |
| May 7, 2026 | Kenison Michael R. | Chief Operations Officer | M | 100 | $0.00 | $0.00 |
| Feb 11, 2026 | Schumacher Daniel | Chief Financial Officer | M | 3,135 | $33.84 | $106.1K |
| Feb 11, 2026 | Schumacher Daniel | Chief Financial Officer | M | 3,135 | $0.00 | $0.00 |
| Feb 10, 2026 | Schumacher Daniel | Chief Financial Officer | F | 6,809 | $53.18 | $362.1K |
| Feb 10, 2026 | Kenison Michael R. | Chief Operations Officer | F | 2,684 | $53.18 | $142.7K |
| Feb 6, 2026 | Kenison Michael R. | Chief Operations Officer | SELL | 2,500 | $60.00 | $150.0K |
| Jan 29, 2026 | Kenison Michael R. | Chief Operations Officer | A | 8,128 | $0.00 | $0.00 |
| Jan 29, 2026 | Schumacher Daniel | Chief Financial Officer | A | 20,686 | $0.00 | $0.00 |
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 2.0/10.
NEUTRAL
8-K
2/10
Proto Labs held its 2026 annual meeting on May 19, 2026, where shareholders elected all seven direct
May 20, 2026
NEUTRAL
8-K
2/10
Proto Labs announced the planned retirement of COO Michael Kenison (effective July 1, 2026) and the
May 7, 2026
NEUTRAL
DEFA14A
2/10
Proto Labs Inc filed a definitive additional proxy statement (DEFA14A) related to an upcoming shareh
Apr 8, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Nov 2025): 73% buy across 11 analysts — 2 strong buy, 6 buy, 3 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Nov 2025. No current recommendation available.
$75.67 mean target (Nov 2025)
$70.00 Low
$82.00 High
| Metric | Value |
|---|---|
| Current Price | $75.48 |
| Target Low | $70.00 |
| Target Mean | $75.67 |
| Target Median | $75.00 |
| Target High | $82.00 |
| # Analysts | 3 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.54 | $0.52 | $0.55 | 31.2% | +0.0% | 5↑ 0↓ | $0.1B | 6.8% | 5 |
| Next Q 2026-09-30 |
$0.51 | $0.48 | $0.55 | 9.4% | +0.0% | 4↑ 1↓ | $0.1B | 7.6% | 5 |
| Current FY 2026-12-31 |
$2.03 | $1.97 | $2.10 | 22.0% | +0.0% | 5↑ 0↓ | $0.6B | 7.2% | 5 |
| Next FY 2027-12-31 |
$2.21 | $2.15 | $2.26 | 9.0% | +11.3% | 4↑ 0↓ | $0.6B | 7.0% | 4 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.538 | |
| 7d ago | $0.538 | |
| 30d ago | $0.538 | |
| 60d ago | $0.466 | +0.072 |
| 90d ago | $0.466 | +0.072 |
16 analyst firms have rated this stock: 4 upgrades, 11 downgrades, 9 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Nov 3, 2025 | Benchmark | MAINTAIN | Buy | Buy |
| Aug 1, 2025 | Cantor Fitzgerald | MAINTAIN | Overweight | Overweight |
| Feb 10, 2025 | Cantor Fitzgerald | MAINTAIN | Overweight | Overweight |
| Feb 7, 2025 | Needham | REITERATE | Hold | Hold |
| Jan 16, 2025 | Needham | REITERATE | Hold | Hold |
| Nov 4, 2024 | Craig-Hallum | MAINTAIN | Hold | Hold |
| Nov 4, 2024 | Cantor Fitzgerald | REITERATE | Overweight | Overweight |
| Nov 1, 2024 | Needham | REITERATE | — | Hold |
| Aug 5, 2024 | Needham | REITERATE | — | Hold |
| Jul 30, 2024 | Cantor Fitzgerald | REITERATE | Overweight | Overweight |
| Jun 5, 2024 | Cantor Fitzgerald | INITIATE | — | Overweight |
| May 29, 2024 | Benchmark | REITERATE | Buy | Buy |
| May 6, 2024 | Craig-Hallum | MAINTAIN | Hold | Hold |
| May 6, 2024 | Needham | REITERATE | — | Hold |
| Aug 7, 2023 | Lake Street | MAINTAIN | Buy | Buy |
| Aug 4, 2023 | Craig-Hallum | UPGRADE | Sell | Hold |
| May 26, 2023 | Benchmark | REITERATE | Buy | Buy |
| May 8, 2023 | Lake Street | MAINTAIN | — | Buy |
| Feb 13, 2023 | Craig-Hallum | MAINTAIN | — | Sell |
| Feb 13, 2023 | Benchmark | UPGRADE | Hold | Buy |
| Feb 2, 2023 | Lake Street | MAINTAIN | — | Buy |
| Nov 29, 2022 | Lake Street | INITIATE | — | Buy |
| Nov 4, 2022 | Craig-Hallum | DOWNGRADE | Hold | Sell |
| Oct 29, 2021 | Benchmark | DOWNGRADE | Buy | Hold |
| May 21, 2021 | Craig-Hallum | MAINTAIN | — | Hold |
| Sep 21, 2020 | Benchmark | MAINTAIN | — | Buy |
| May 14, 2020 | Benchmark | INITIATE | — | Buy |
| Jan 23, 2020 | Berenberg | DOWNGRADE | Buy | Hold |
| Oct 25, 2019 | William Blair | DOWNGRADE | Outperform | Market Perform |
| Oct 25, 2019 | Northcoast Research | DOWNGRADE | Buy | Neutral |
| Dec 12, 2018 | Northcoast Research | INITIATE | — | Buy |
| Oct 28, 2016 | Canaccord Genuity | DOWNGRADE | Buy | Hold |
| May 11, 2016 | FBR Capital | INITIATE | — | Outperform |
| Apr 29, 2016 | Stephens & Co. | DOWNGRADE | Overweight | Equal-Weight |
| Apr 29, 2016 | Stephens & Co. | DOWNGRADE | Overweight | Equal-Weight |
| Oct 15, 2015 | Canaccord Genuity | UPGRADE | Hold | Buy |
| Apr 24, 2015 | Craig-Hallum | DOWNGRADE | Buy | Hold |
| Apr 24, 2015 | Piper Sandler | DOWNGRADE | Overweight | Neutral |
| Apr 20, 2015 | Needham | DOWNGRADE | Buy | Hold |
| Feb 19, 2015 | Pacific Crest | INITIATE | — | Sector Perform |
| Dec 18, 2014 | Oppenheimer | INITIATE | — | Outperform |
| Oct 3, 2014 | Canaccord Genuity | UPGRADE | Hold | Buy |
| Jun 18, 2014 | Canaccord Genuity | INITIATE | — | Hold |
| May 2, 2014 | Jefferies | MAINTAIN | — | Hold |
| Jul 15, 2013 | Jefferies | MAINTAIN | — | Hold |
| Jun 17, 2013 | Piper Sandler | MAINTAIN | — | Overweight |
| Apr 25, 2013 | Piper Sandler | MAINTAIN | — | Overweight |
| Feb 21, 2013 | Morgan Stanley | INITIATE | — | Equal-Weight |
| Feb 13, 2013 | Piper Sandler | MAINTAIN | — | Overweight |
| Feb 13, 2013 | Jefferies | MAINTAIN | — | Hold |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 6 | 3 | 0 | 0 | 73% | |
| May 1, 2026 | 2 | 6 | 3 | 0 | 0 | 73% | |
| Apr 1, 2026 | 2 | 6 | 3 | 0 | 0 | 73% | |
| Mar 1, 2026 | 2 | 6 | 3 | 0 | 0 | 73% | |
| Feb 1, 2026 | 2 | 6 | 3 | 0 | 0 | 73% | |
| Jan 1, 2026 | 2 | 6 | 3 | 0 | 0 | 73% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 1, 2026
earnings_calendar
PRLB Q1 2026 Earnings Scheduled — 2026-05-01